![A Comparison of Ceftriaxone and Cefuroxime for the Treatment of Bacterial Meningitis in Children | NEJM A Comparison of Ceftriaxone and Cefuroxime for the Treatment of Bacterial Meningitis in Children | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/1990/nejm_1990.322.issue-3/nejm199001183220301/20130822/images/img_medium/nejm199001183220301_t4.jpeg)
A Comparison of Ceftriaxone and Cefuroxime for the Treatment of Bacterial Meningitis in Children | NEJM
![High-Dose Ceftriaxone for Bacterial Meningitis and Optimization of Administration Scheme Based on Nomogram | Antimicrobial Agents and Chemotherapy High-Dose Ceftriaxone for Bacterial Meningitis and Optimization of Administration Scheme Based on Nomogram | Antimicrobial Agents and Chemotherapy](https://journals.asm.org/cms/10.1128/AAC.00634-19/asset/3aaa9e43-4262-4cec-8469-de1167a023c8/assets/graphic/aac.00634-19-t0001.jpeg)
High-Dose Ceftriaxone for Bacterial Meningitis and Optimization of Administration Scheme Based on Nomogram | Antimicrobial Agents and Chemotherapy
![1g versus 2 g daily intravenous ceftriaxone in the treatment of community onset pneumonia – a propensity score analysis of data from a Japanese multicenter registry | BMC Infectious Diseases | Full Text 1g versus 2 g daily intravenous ceftriaxone in the treatment of community onset pneumonia – a propensity score analysis of data from a Japanese multicenter registry | BMC Infectious Diseases | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12879-019-4552-8/MediaObjects/12879_2019_4552_Fig1_HTML.png)
1g versus 2 g daily intravenous ceftriaxone in the treatment of community onset pneumonia – a propensity score analysis of data from a Japanese multicenter registry | BMC Infectious Diseases | Full Text
![Prevalence and nature of off-label antibiotic prescribing for children in a tertiary setting: a descriptive study from Jordan Prevalence and nature of off-label antibiotic prescribing for children in a tertiary setting: a descriptive study from Jordan](https://scielo.isciii.es/img/revistas/pharmacy/v14n3/original2_t4.gif)